Sino Biopharmaceutical Limited
OTC: SBMFF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- S. Y. Tse
- Employees
- 24,379
- Headquarters
- Wan Chai, Hong Kong SAR China
- IPO year
- 2010
- Market cap
- $10.7B
- Website
- https://www.sinobiopharm.com
Loading SBMFF…
Loading profile data…Frequently asked questions about SBMFF
What does Sino Biopharmaceutical Limited (SBMFF) do?
Sino Biopharmaceutical Limited operates as a leading investment holding entity and a research and development-focused pharmaceutical conglomerate, primarily active within the People's Republic of China. Its business activities are organized into three primary divisions: Modernised Chinese Medicines and Chemical Medicines, Investment initiatives,...
Where does SBMFF trade?
Sino Biopharmaceutical Limited (SBMFF) trades on the Other OTC.
What sector is SBMFF in?
Sino Biopharmaceutical Limited (SBMFF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sino Biopharmaceutical Limited?
S. Y. Tse is the chief executive officer of Sino Biopharmaceutical Limited (SBMFF).
Where is Sino Biopharmaceutical Limited headquartered?
Sino Biopharmaceutical Limited is headquartered in Hong Kong SAR China.
Does SBMFF pay a dividend?
Yes — Sino Biopharmaceutical Limited (SBMFF) paid a trailing twelve-month dividend of USD 0.01 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SBMFF go public?
Sino Biopharmaceutical Limited (SBMFF) completed its initial public offering in 2010.